To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene STAP2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
165 supporting clones for gene STAP2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_017720.2   .a 1 to 1536 1 to 1536 exact RefSeq, AAA   1536/1536
(100 %)
0 diff
(100 %id)
AK000241 colon mucosa .a 30 to 1536 1 to 1507   tiling clone, available from FLJ, AAA   1507/1507
(100 %)
4 diff
(99.8 %id)
BG824265 adenocarcinoma cell line, colon .a 485 to 1367 1 to 886   tiling clone,   884/887
(99 %)
19 diff
(97.9 %id)
AW152661 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1104 to 1533 430 to 1       430/430
(100 %)
0 diff
(100 %id)
BM695192 eye, optic nerve .b 1 to 734 1 to 728   tiling clone,   730/729
(100 %)
8 diff
(99.0 %id)
AA449638   .b 106 to 569 9 to 471       463/471
(98 %)
8 diff
(98.4 %id)
BM666369 eye, optic nerve .b 872 to 1466 613 to 19   tiling clone, AAA   595/595
(100 %)
0 diff
(100 %id)
AA449475   .b 1080 to 1466 388 to 1       388/388
(100 %)
3 diff
(99.3 %id)
DA682042 ovary .c 1 to 549 2 to 550   tiling clone, capped   549/549
(100 %)
1 diff
(99.9 %id)
CX759758 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 21 to 778 1 to 757     Submitted on the opposite strand 757/757
(100 %)
2 diff
(99.8 %id)
CX757501 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 21 to 750 1 to 730     Submitted on the opposite strand 730/730
(100 %)
1 diff
(99.9 %id)
BF677969 Prostate .c 28 to 707 1 to 679       679/696
(97 %)
18 diff
(97.5 %id)
NM_001013841.1   .c 28 to 1425 1 to 1398 exact RefSeq, AAA   1398/1398
(100 %)
0 diff
(100 %id)
DA427510 colon .c 45 to 542 2 to 500   capped   499/499
(100 %)
3 diff
(99.4 %id)
BI859367 breast, mammary adenocarcinoma, cell line .c 45 to 802 1 to 760       760/760
(100 %)
4 diff
(99.5 %id)
TI_57190839   .c 45 to 802 55 to 814       760/760
(100 %)
4 diff
(99.5 %id)
DA427983 colon .c 47 to 616 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BP330675 rectum .c 47 to 629 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BM791218 stomach .c 50 to 655 1 to 606       606/606
(100 %)
1 diff
(99.9 %id)
CB141635 Liver .c 52 to 524 1 to 475       475/475
(100 %)
4 diff
(99.2 %id)
BP330495 rectum .c 53 to 648 1 to 596       596/596
(100 %)
2 diff
(99.7 %id)
CB116885 Liver .c 54 to 265 1 to 212       212/212
(100 %)
0 diff
(100 %id)
BP203744 coronary artery .c 55 to 634 1 to 580       580/584
(99 %)
8 diff
(98.7 %id)
BP331195 rectum .c 57 to 640 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BP262184 small intestine .c 60 to 642 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DB010514 colon, tumor tissue .c 61 to 579 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
BP267238 thyroid .c 62 to 642 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
AJ245719 normal breast .c 67 to 1422 1 to 1356 D93N     1356/1356
(100 %)
1 diff
(100.0 %id)
BP320906 placenta .c 70 to 662 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
BP263634 small intestine .c 71 to 647 1 to 578       578/578
(100 %)
2 diff
(99.7 %id)
BM788118 Ascites, stomach .c 71 to 656 1 to 586       586/586
(100 %)
1 diff
(99.9 %id)
BM781674 Ascites, stomach .c 71 to 777 1 to 707       707/707
(100 %)
1 diff
(99.9 %id)
BM772752 Ascites, stomach .c 71 to 528 1 to 461       461/461
(100 %)
34 diff
(92.7 %id)
BP330684 rectum .c 72 to 654 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP263199 small intestine .c 73 to 648 1 to 576       576/576
(100 %)
5 diff
(99.2 %id)
BP351756   .c 73 to 662 1 to 589       589/598
(98 %)
9 diff
(98.5 %id)
BM051123 eye, normal pigmented retinal epithelium .c 75 to 540 1 to 468       468/470
(99 %)
5 diff
(99.0 %id)
BC000795 Placenta, choriocarcinoma .c 77 to 1425 1 to 1349 D93N tiling clone, available from MGC, AAA   1349/1349
(100 %)
1 diff
(100.0 %id)
BG534426 lung .c 81 to 800 1 to 720       720/721
(99 %)
2 diff
(99.8 %id)
BP328905 rectum .c 82 to 662 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CR596893 T cells (Jurkat cell line) Cot10-normalized .c 85 to 1370 1 to 1286 exact tiling clone,   1286/1286
(100 %)
0 diff
(100 %id)
AL559086 T cells from T cell leukemia .c 85 to 932 1 to 848       848/848
(100 %)
1 diff
(99.9 %id)
BM820456 stomach .c 86 to 341 1 to 256       256/256
(100 %)
0 diff
(100 %id)
BM821216 stomach .c 86 to 538 1 to 453       453/453
(100 %)
1 diff
(99.8 %id)
BI754191 brain .c 87 to 714 1 to 627       627/627
(100 %)
2 diff
(99.7 %id)
TI_57217615   .c 87 to 714 72 to 698       627/698
(89 %)
7 diff
(99.0 %id)
BG740811 skin .c 89 to 802 1 to 714       714/714
(100 %)
0 diff
(100 %id)
BP260590 small intestine .c 91 to 673 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BP261288 small intestine .c 91 to 672 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP223986 colon mucosa .c 92 to 721 1 to 636       636/842
(75 %)
14 diff
(98.4 %id)
BG752481 eye, normal pigmented retinal epithelium .c 93 to 839 1 to 787       684/787
(86 %)
50 diff
(93.7 %id)
BG752660 eye, normal pigmented retinal epithelium .c 93 to 801 1 to 709       709/709
(100 %)
0 diff
(100 %id)
BE870847 adenocarcinoma, colon .c 97 to 842 1 to 748       748/780
(95 %)
21 diff
(97.4 %id)
BE536748 cervix .c 98 to 721 1 to 625       625/731
(85 %)
31 diff
(95.8 %id)
BG248137 adenocarcinoma cell line, colon .c 98 to 852 1 to 750       752/891
(84 %)
17 diff
(98.1 %id)
BG386239 adenocarcinoma cell line, colon .c 98 to 756 1 to 659       659/659
(100 %)
1 diff
(99.9 %id)
BG821254 adenocarcinoma cell line, colon .c 98 to 784 1 to 690       690/704
(98 %)
12 diff
(98.3 %id)
BG421217 Kidney, renal cell adenocarcinoma .c 99 to 785 1 to 688       688/933
(73 %)
11 diff
(98.9 %id)
BI765700 pooled colon, kidney, stomach .c 101 to 804 27 to 728       702/729
(96 %)
7 diff
(99.1 %id)
TI_57149293   .c 101 to 804 27 to 728       702/729
(96 %)
7 diff
(99.1 %id)
BM552002 astrocytoma grade IV, cell line, brain .c 108 to 1168 1 to 1071       1034/1073
(96 %)
28 diff
(97.4 %id)
CB161171 Liver .c 113 to 655 1 to 543       543/543
(100 %)
0 diff
(100 %id)
CN427167 embryonic stem cells, DMSO-treated H9 cellline .c 114 to 784 1 to 672       672/675
(99 %)
2 diff
(99.8 %id)
CN427170 embryonic stem cells, cell lines H1, H7, andH9 .c 114 to 542 1 to 429       429/429
(100 %)
3 diff
(99.4 %id)
CN427169 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 123 to 902 1 to 780       780/780
(100 %)
6 diff
(99.3 %id)
BU956623 adenocarcinoma, cell line, breast .c 146 to 964 1 to 825       825/884
(93 %)
13 diff
(98.6 %id)
CN427171 embryonic stem cells, cell lines H1, H7, andH9 .c 148 to 742 1 to 595       595/595
(100 %)
0 diff
(100 %id)
BG679744 skin, squamous cell carcinoma .c 208 to 923 1 to 716       716/716
(100 %)
8 diff
(98.9 %id)
W32179 parathyroid gland, parathyroid tumor .c 350 to 795 1 to 453       453/453
(100 %)
13 diff
(97.2 %id)
AL580782 T cells from T cell leukemia .c 501 to 1370 871 to 1       871/871
(100 %)
4 diff
(99.6 %id)
BG748057 eye, normal pigmented retinal epithelium .c 528 to 1399 1 to 876       876/881
(99 %)
17 diff
(98.1 %id)
TI_149297812   .c 542 to 1425 958 to 86   AAA   873/1011
(86 %)
26 diff
(97.5 %id)
AI478843 pooled .c 606 to 1424 815 to 1       815/815
(100 %)
21 diff
(97.5 %id)
DR422512 eye, Pterygium .c 640 to 1323 1 to 683       683/683
(100 %)
4 diff
(99.5 %id)
TI_149294483   .c 714 to 1425 794 to 86   AAA   709/788
(89 %)
13 diff
(98.4 %id)
CB048813 Prostate .c 745 to 1426 10 to 691       682/692
(98 %)
8 diff
(98.9 %id)
CB850669 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 751 to 1425 694 to 19   AAA   676/676
(100 %)
1 diff
(99.9 %id)
BM980638 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 755 to 1425 689 to 19   AAA   671/671
(100 %)
0 diff
(100 %id)
BU622670 cell lines, Chondrosarcoma .c 756 to 1425 688 to 19   AAA   670/670
(100 %)
3 diff
(99.6 %id)
BM708627 eye, RPE and Choroid .c 783 to 984 1 to 202   fully sequenced,   202/202
(100 %)
0 diff
(100 %id)
BG824378 adenocarcinoma cell line, colon .c 818 to 1426 1 to 610       610/907
(67 %)
5 diff
(99.5 %id)
BX460577 brain, fetal brain .c 822 to 1426 1 to 605       605/605
(100 %)
1 diff
(99.9 %id)
BX413175 brain, fetal brain .c 822 to 1414 599 to 8       592/599
(98 %)
1 diff
(99.9 %id)
BX107197 liver and spleen .c 884 to 1425 1 to 542   AAA   542/542
(100 %)
0 diff
(100 %id)
H94805 liver and spleen .c 885 to 1165 1 to 281   fully sequenced,   281/281
(100 %)
0 diff
(100 %id)
BU683238 lung .c 886 to 1425 557 to 19   AAA   539/539
(100 %)
2 diff
(99.7 %id)
AA628092 normal prostate, Prostate .c 888 to 1426 544 to 7       538/544
(98 %)
0 diff
(100 %id)
BQ376683 uterus .c 898 to 1267 381 to 11       371/394
(94 %)
6 diff
(98.5 %id)
AI813678 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 901 to 1424 525 to 1       525/525
(100 %)
2 diff
(99.7 %id)
AW269372 Kidney .c 903 to 1425 524 to 1       524/524
(100 %)
7 diff
(98.7 %id)
BF515055   .c 905 to 1425 538 to 18   AAA   521/521
(100 %)
0 diff
(100 %id)
BU730961 eye, RPE and Choroid .c 923 to 1425 521 to 19   fully sequenced, AAA   503/503
(100 %)
1 diff
(99.9 %id)
BE222663 brain, oligodendroglioma .c 936 to 1425 505 to 16   AAA   490/490
(100 %)
1 diff
(99.8 %id)
AI742137 pooled .c 952 to 1411 462 to 2       461/462
(99 %)
1 diff
(99.8 %id)
AW511181 pooled .c 958 to 1421 467 to 3       465/467
(99 %)
0 diff
(100 %id)
BM545041 ovary (pool of 3) .c 975 to 1425 16 to 477   AAA   473/477
(99 %)
56 diff
(88.3 %id)
BF002889 Prostate .c 979 to 1426 452 to 5       448/452
(99 %)
0 diff
(100 %id)
BE645175 pooled .c 982 to 1426 452 to 8       445/452
(98 %)
1 diff
(99.8 %id)
AA722779 heart .c 997 to 1425 429 to 1       429/429
(100 %)
3 diff
(99.4 %id)
AI887196 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 998 to 1425 449 to 22   AAA   428/428
(100 %)
5 diff
(98.9 %id)
AI363399 anaplastic oligodendroglioma, brain .c 1006 to 1423 420 to 3       418/420
(99 %)
0 diff
(100 %id)
AA890712 parathyroid gland, parathyroid tumor .c 1011 to 1425 430 to 16   AAA   415/415
(100 %)
14 diff
(96.7 %id)
AA740417 2 pooled tumors (clear cell type), Kidney .c 1012 to 1425 423 to 12   AAA   412/412
(100 %)
2 diff
(99.6 %id)
AW593063 pooled .c 1014 to 1418 405 to 1       405/405
(100 %)
2 diff
(99.6 %id)
BG979893 colon_normal .c 1028 to 1272 33 to 277       245/288
(85 %)
8 diff
(97.3 %id)
BE858978 Prostate .c 1054 to 1424 376 to 6       371/379
(97 %)
1 diff
(99.8 %id)
AA410876 ovarian tumor, ovary .c 1055 to 1416 1 to 352       352/352
(100 %)
12 diff
(96.6 %id)
BP387589 pancreatic islet .c 1059 to 1426 371 to 3       369/373
(98 %)
2 diff
(99.5 %id)
BP397788 pancreatic islet .c 1064 to 1408 1 to 345     Submitted on the opposite strand 345/345
(100 %)
4 diff
(98.9 %id)
AI743293 pooled .c 1070 to 1425 371 to 16   AAA   356/356
(100 %)
2 diff
(99.5 %id)
AI391652 B-cell, chronic lymphotic leukemia .c 1083 to 1425 356 to 14   AAA   343/343
(100 %)
1 diff
(99.8 %id)
CB049848 Prostate .c 1097 to 1421 5 to 330       329/330
(99 %)
9 diff
(97.3 %id)
H61131 ovarian tumor, ovary .c 1103 to 1430 349 to 12       338/410
(82 %)
12 diff
(97.1 %id)
AI280434 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1103 to 1426 329 to 6       324/331
(97 %)
1 diff
(99.7 %id)
BF063529 colon, colon tumor, RER+ .c 1105 to 1316 203 to 1       203/247
(82 %)
14 diff
(94.4 %id)
AW001746 Kidney .c 1114 to 1426 317 to 5       313/317
(98 %)
1 diff
(99.7 %id)
AI474205 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1134 to 1425 292 to 1       292/298
(97 %)
0 diff
(100 %id)
H95343 liver and spleen .c 1135 to 1426 292 to 3   fully sequenced,   290/292
(99 %)
1 diff
(99.7 %id)
AI832281 colon .c 1151 to 1425 275 to 1       275/275
(100 %)
0 diff
(100 %id)
W32215 parathyroid gland, parathyroid tumor .c 1167 to 1422 265 to 8       258/266
(96 %)
3 diff
(98.9 %id)
BF437542 Prostate .c 1174 to 1422 250 to 2       249/250
(99 %)
0 diff
(100 %id)
BF437662 Prostate .c 1174 to 1423 251 to 2       250/251
(99 %)
0 diff
(100 %id)
AI872611 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1202 to 1425 238 to 15   AAA   224/224
(100 %)
1 diff
(99.6 %id)
BQ300612 bladder_tumor .c 1227 to 1424 211 to 10       202/213
(94 %)
9 diff
(95.8 %id)
AK125774 testis .d 1 to 2042 2 to 2043   tiling clone, available from FLJ,   2043/2043
(100 %)
0 diff
(100 %id)
DB059651 testis .d 1 to 505 2 to 506   capped   505/505
(100 %)
0 diff
(100 %id)
TI_57214787   .d 460 to 1283 67 to 909       588/909
(64 %)
30 diff
(96.7 %id)
EL594179 epidermis, skin .d 707 to 1390 27 to 710       687/720
(95 %)
11 diff
(98.5 %id)
BG740178 skin .d 776 to 1404 1 to 629       629/629
(100 %)
5 diff
(99.3 %id)
BE702997 nervous_normal .d 777 to 940 23 to 186       172/186
(92 %)
6 diff
(96.8 %id)
BG741320 skin .d 777 to 1583 1 to 805       805/806
(99 %)
13 diff
(98.4 %id)
R46440 breast .d 848 to 1075 1 to 229       229/229
(100 %)
2 diff
(99.2 %id)
BM856618 stomach .d 918 to 1184 1 to 265       265/270
(98 %)
4 diff
(98.6 %id)
CN427168 embryonic stem cells, DMSO-treated H9 cellline .d 950 to 1457 1 to 508       508/508
(100 %)
1 diff
(99.9 %id)
CU452907 epidermis .d 1004 to 1391 401 to 14     Submitted on the opposite strand 388/422
(91 %)
0 diff
(100 %id)
AW605401 denis_drash .d 1238 to 1510 38 to 316       281/332
(84 %)
18 diff
(94.6 %id)
BU166523 melanotic melanoma, cell line, skin .d 1256 to 1750 1 to 510       507/887
(57 %)
15 diff
(98.4 %id)
BE140449 head_neck .d 1266 to 1508 13 to 254       242/254
(95 %)
10 diff
(96.1 %id)
BG959834 colon .d 1363 to 1577 10 to 220       215/220
(97 %)
9 diff
(96.0 %id)
BF800573 colon_ins .d 1382 to 1585 312 to 109     Submitted on the opposite strand 204/312
(65 %)
0 diff
(100 %id)
BE772509 prostate_tumor .d 1406 to 1555 168 to 19       150/168
(89 %)
0 diff
(100 %id)
AI459617 colon .d 1619 to 2042 440 to 17   AAA   424/424
(100 %)
1 diff
(99.8 %id)
DB339137 testis .d 1665 to 2042 378 to 1       378/378
(100 %)
0 diff
(100 %id)
CB306316 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 1717 to 2042 344 to 19   AAA   326/326
(100 %)
14 diff
(95.8 %id)
AI190504 heart .d 1729 to 2042 328 to 15   AAA   314/314
(100 %)
0 diff
(100 %id)
AI282582 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1792 to 2043 253 to 2   tiling clone,   252/253
(99 %)
0 diff
(100 %id)
BG151800 colon, normal colonic mucosa .d 1897 to 2039 154 to 11   AAA   144/179
(80 %)
1 diff
(99.5 %id)
BU539655 adenocarcinoma, cell line, breast .e 1 to 826 16 to 848   tiling clone,   833/937
(88 %)
26 diff
(97.3 %id)
BG248487 adenocarcinoma cell line, colon .e 29 to 760 1 to 730   tiling clone,   730/946
(77 %)
15 diff
(98.5 %id)
AA643210 epithelium (cell line), Prostate .e 740 to 1146 412 to 6   tiling clone,   407/412
(98 %)
0 diff
(100 %id)
AW591698 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 856 to 1147 329 to 38   tiling clone, AAA   292/292
(100 %)
1 diff
(99.7 %id)
BM797704 Ascites, stomach .f 1 to 405 11 to 415   tiling clone,   405/415
(97 %)
10 diff
(97.6 %id)
AI816845 2 pooled tumors (clear cell type), Kidney .f 371 to 938 573 to 6   tiling clone,   568/573
(99 %)
0 diff
(100 %id)
AI310217 2 pooled tumors (clear cell type), Kidney .f 393 to 938 551 to 6       546/551
(99 %)
0 diff
(100 %id)
BE348262 Kidney .f 455 to 938 487 to 4       484/487
(99 %)
0 diff
(100 %id)
BG676819 skin, squamous cell carcinoma .g 1 to 769 1 to 765   tiling clone,   765/766
(99 %)
26 diff
(96.7 %id)
BG677314 skin, squamous cell carcinoma .g 144 to 822 1 to 684   tiling clone,   684/684
(100 %)
12 diff
(98.3 %id)
BM826020 Ascites, stomach .g 664 to 1056 1 to 393   tiling clone,   393/393
(100 %)
1 diff
(99.8 %id)
CN427172 embryonic stem cells, DMSO-treated H9 cellline .g 728 to 1349 1 to 622       622/622
(100 %)
2 diff
(99.7 %id)
TI_154095064   .g 982 to 1441 575 to 116   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 460/849
(54 %)
5 diff
(99.5 %id)
CX784677 human embryonic stem cells .h 1 to 818 1 to 816 exact tiling clone,   816/816
(100 %)
3 diff
(99.7 %id)
BP317860 pericardium .i 1 to 583 1 to 583 G87S A149C K150Q Q170X S178L tiling clone,   583/583
(100 %)
7 diff
(98.8 %id)
CV810176 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .j 1 to 805 1 to 806 exact tiling clone,   806/806
(100 %)
14 diff
(98.3 %id)
CA487562   .k 1 to 620 1 to 622 W129X A130X P131T tiling clone,   622/849
(73 %)
24 diff
(97.2 %id)
AI362725 anaplastic oligodendroglioma, brain .l 1 to 373 394 to 22 T71P A72T L74V E80K H93P tiling clone, AAA   373/373
(100 %)
14 diff
(96.3 %id)
AI261631 Kidney .l 44 to 374 337 to 7   tiling clone,   331/337
(98 %)
0 diff
(100 %id)
AW609756 stomach .m-u 1 to 262 1 to 262 C21Y tiling clone,   262/269
(97 %)
2 diff
(99.3 %id)
BQ879959 ductal carcinoma, cell line, Pancreas Gene STAP2, variant not shown         Suspected internal deletion, this clone was ignored    
BQ687440 ductal carcinoma, cell line, Pancreas Gene STAP2, variant not shown         Suspected internal deletion, this clone was ignored    
TI_149302441   Gene STAP2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
TI_157613543   Gene STAP2, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI